Home » Newsletters » BioWorld Science

BioWorld Science

April 5, 2011

View Archived Issues

Noninvasive method predicts organ rejection using donor DNA levels in transplant recipient's plasma

Lab-on-a-chip device SIMBAS enables quick separation of parasites from human blood

Antitumor effects of tolfenamic acid correlate with downregulation of transcription factors Sp1/3/4

Glenmark Pharma begins IND-enabling studies for GBR-401

Orexo advances development of OX-51 for pain

CPP-109 enters trial for cocaine and alcohol addiction

Astellas licenses three agents to Cardeus Pharma

America Stem Cell's ASC-101 obtains FDA orphan drug status

Novel microtubule-disrupting agents claimed

Enrollment begins in phase III EMPOWER trial of dexpramipexole in ALS

NeuroSearch patents new modulators of voltage-gated potassium channels

ISP Investments presents new protein-glutamine gamma-glutamyltransferase activator

Quest Diagnostics acquires Athena Diagnostics

Pfizer receives FDA refuse to file letter for tafamidis in TTR-FAP

Avanir Pharma files IND for AVP-923 for neuropathic pain in MS

Tibotec scientists design novel anti-HCV agents

New inhibitors of cyclin-dependent kinase 9 patented by Novartis

Pan-Akt inhibitor GDC-0068 demonstrates in vivo antitumor effects

Morphotek acquires tumor-targeting peptide platform from TransMolecular

Boston Scientific reports data on new alloy and stent design

Final SELECT-2 data show CR2b is efficacious against hepatitis C when dosed every 2 weeks

Daiichi Sanyko completes acquisition of Plexxikon

Reporting of final results of phase II AZX-100 trial to be delayed

Abstral launched in U.S. for breakthrough cancer pain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...